No Prescription |
 |
 | ||
|
BUPRON SR 150 Zyban |
|
| ||
No Prescription » Prescription Drugs 3 » BUPRON SR 150 Zyban Bupropion is used to treat depression. It can improve your mood and feelings of well-being. It may work by helping to restore the balance of certain natural chemicals (neurotransmitters) in your brain.The sustained release form of bupropion is also used to help people quit smoking by decreasing cravings and nicotine withdrawal effects.OTHER USES: This section contains uses of this drug that are not listed in the approved professional labeling for the drug but that may be prescribed by your health care professional. Use this drug for a condition that is listed in this section only if it has been so prescribed by your health care professional.Bupropion may also be used to treat attention deficit hyperactivity disorder (ADHD). This drug may also be used with other medications to treat bipolar disorder (depressive phase).How to use Bupropion OralRead the Patient Information Leaflet and Medication Guide available from your pharmacist before you start using bupropion and each time you get a refill. Consult your doctor or pharmacist if you have any questions.Take this medication by mouth with or without food usually three times daily. If stomach upset occurs you may take this drug with food. It is important to take your doses at least 6 hours apart or as directed by your doctor to decrease your risk of having a seizure.Do not take more or less medication or take it more frequently than prescribed. Taking more than the recommended dose of bupropion may increase your risk of having a seizure. Do not take more than 150 milligrams as a single dose and do not take more than 450 milligrams per day.Your dosage is based on your medical condition and response to therapy. Your dose may be slowly increased to limit side effects such as sleeplessness and to decrease the risk of seizures. To avoid trouble sleeping do not take this medication too close to bedtime. Let your doctor know if sleeplessness becomes a problem.Use this medication regularly in order to get the most benefit from it. To help you remember use it at the same times each day.Do not stop taking this medication without consulting your doctor. Some conditions may become worse when the drug is suddenly stopped. Your dose may need to be gradually decreased.It may take 4 or more weeks before you notice the full benefit of this drug. Continue to take this medication as directed by your doctor even after you feel better. Talk to your doctor if your condition does not improve or if it worsens. Buy BUPRON SR 150 Zyban and other Prescription Drugs 3 products online at Medstore. 419
About BUPRON SR 150 Zyban: Product Type: Prescription Drugs 3 BUPRON SR 150 ( Zyban Wellbrutin SR Generic Bupropion ) BUPRON SR 150 (Zyban Wellbrutin SR Generic Bupropion) Zyban Wellbrutin SR Generic Bupropion 150mg Tabs 30 (3 x 10) Zyban Wellbrutin SR Generic Bupropion BUPRON SR 150
View more Prescription Drugs 3 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
